首页 | 本学科首页   官方微博 | 高级检索  
检索        

2009年我院先天性心脏病产前筛查和干预的成本效益分析
引用本文:江虹,常宏,李志玲,赵光临.2009年我院先天性心脏病产前筛查和干预的成本效益分析[J].临床合理用药杂志,2012,5(1):27-28.
作者姓名:江虹  常宏  李志玲  赵光临
作者单位:1. 南方医科大学附属深圳市妇幼保健院药剂科,广东省深圳市,518028
2. 南方医科大学附属深圳市妇幼保健院信息科,广东省深圳市,518028
基金项目:深圳市科技计划项目(No:201003111)
摘    要:目的分析2009年该院30 582例孕妇的筛查和238例先天性心脏病(先心病)患儿诊断治疗和干预的成本效益。方法对实际发生的筛查和干预、治疗成本进行成本测算,估算干预成本效益。结果先心病筛查干预措施的效益成本比率为5∶1。结论证实先心病产前筛查对先心病的干预具有重要意义。

关 键 词:心脏病  先天性  产前筛查  成本效益分析

Cost-benefit analysis of prenatal screening and intervention of congenital heart disease in our hospital in 2009
Institution:JIANG Hong*,CHANG Hong,LI Zhi-ling,et al.*Department of Pharmacy,Southern Medical University Affiliated Maternity and Child Healthcare Hospital in Shenzhen,Shenzhen,Guangdong 518028,China
Abstract:Objective The related data of 30 582 pregnant women and 238 congenital heart disease cases in hospital in 2009 were collected during the study period.Methods Cost-benefit analysis was applied to evaluate the congenital heart disease screening and prevention method.Results The actual cost of the screening,prevention and treatment was measured,while the benefit of the prevention was evaluated.The result indicated that the ratio of cost for prenatal screening benefit was 5 times.Conclusion It proved strongly that per-maternity screening played an important role in the prevention of congenital heart disease.
Keywords:Heart disease  congenital  Prenatal screening  Cost-benefit analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号